Evidence map›Paper›PMID 39807271›Full record

ArticleJournal of traditional and complementary medicine2025

Therapeutic efficacy of

Kayalvizhi Rajendran, David Raj Chellappan, Vigneshwar Ramakrishnan, Uma Maheswari Krishnan

Abstract read
In one paragraph

Article in Journal of traditional and complementary medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Antioxidant efficacy ofAvicenna journal of phytomedicine · 2026
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kayalvizhi RajendranSchool of Chemical & Biotechnology, SASTRA Deemed University, Thanjavur, India.
David Raj ChellappanSchool of Chemical & Biotechnology, SASTRA Deemed University, Thanjavur, India.
Vigneshwar RamakrishnanSchool of Chemical & Biotechnology, SASTRA Deemed University, Thanjavur, India.
Uma Maheswari KrishnanSchool of Chemical & Biotechnology, SASTRA Deemed University, Thanjavur, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background & aim: Hemolytic anemia is a blood disorder whose incidence is increasing in the world in recent years especially after the pandemic. Conventional treatments include use of steroids and immunosuppresants that are accompanied by numerous adverse effects. With growing interest in using complex multi-component formulations for multi-targeted therapy, the present study aims to investigate the therapeutic efficacy of a traditional Experimental approaches: We employ a combination of Results and conclusion: The

Indexed as

AyurvedaGamna gandy bodiesHemolytic anaemiaMolecular dockingPunarnavadi manduraTNF-Alpha

Identifiers

PMID39807271
PMCPMC11725071

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.